Molecules / Pemetrexed Disodium Hemipentahydrate

Pemetrexed Disodium Hemipentahydrate API manufacturers

Updated 9 July 2026
5
manufacturers with an active filing 0 of them hold a US DMF or a CEP
5
shortage records on file across 1 countries
31
finished-dose makers across 5 regulators
Showing 5 of 5 manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked API manufacturers

01

Shilpa Pharma Lifesciences

India
Makes the API

Registered with SFDA (Saudi Arabia) for pemetrexed disodium hemipentahydrate. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.

US DMF
None on file
CEP
None on file
Last FDA inspection
2025 · NAI
GMP recognised in
1 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile
02

Fujian South Pharmaceutical

China
Makes the API

Registered with SFDA (Saudi Arabia) for pemetrexed disodium hemipentahydrate. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 1 market.

US DMF
None on file
CEP
None on file
Last FDA inspection
2024 · NAI
GMP recognised in
1 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile
03

Huzhou Zhanwang Pharmaceutical

China
Makes the API

Registered with SFDA (Saudi Arabia) for pemetrexed disodium hemipentahydrate. Its 2024 FDA inspection closed as NAI.

US DMF
None on file
CEP
None on file
Last FDA inspection
2024 · NAI
GMP recognised in
Not established
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile
04

Kyongbo Pharmaceutical

South Korea
Makes the API

Registered with SFDA (Saudi Arabia) for pemetrexed disodium hemipentahydrate. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.

US DMF
None on file
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
2 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile
05

Cdymax (India) Pharma

India
Makes the API

Registered with SFDA (Saudi Arabia) for pemetrexed disodium hemipentahydrate. Its GMP is recognised in 1 market.

US DMF
None on file
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
1 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile

2 more manufacturers hold filings for pemetrexed disodium hemipentahydrate

The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.

Kyongbo PharmaceuticalCdymax (India) Pharma
Open the full list with a free account

Finished-dose makers (6)

Zentiva, k.s Czech Republic Sandoz Switzerland Pfizer Brasil Ltda Brazil Pt Ckd Otto Pharmaceuticals Indonesia Ferron Par Pharmaceuticals Indonesia Fonko International Pharmaceuticals Indonesia

How this list is built

The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.

Active US DMFs
FDA, List of Drug Master Files
Valid CEPs
EDQM certificate database
Inspection outcomes
FDA inspection classifications
GMP certificates
EudraGMDP and national regulators

Map pemetrexed disodium hemipentahydrate for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

Also on this molecule

Shortages 5 Finished dose 6 Contract mfrs 0